Table 1.
AT/RT-SHH/Group 1 | AT/RT-TYR/Group 2A | AT/RT-MYC/Group 2B | |
---|---|---|---|
Location | Supratentorial > infratentorial | Infratentorial >> supratentorial | Supratentorial >> infratentorial |
Mutation type | Focal SMARCB1 mutations | Broad SMARCB1 deletions (ie, 22q loss). | Focal SMARCB1 deletions |
DNA methylation status | Hypermethylated | Hypermethylated | Hypomethylated |
Dysregulated molecular pathways | NOTCH, SHH, EZH2, CDK6 | MITF, OTX2, CCND1, VEGFA | HOX, EZH2 |
BMP, PDGFRB, MYC, ERBB2 | |||
Published representative cell lines | CHLA02, CHLA04, CHLA05 | BT12, BT16, SH, CHLA06, CHLA266 |
Abbreviations: BMP, bone morphogenic protein; CCND1, cyclin D1; MITF, micropthalmia-associated transcription factor; PDGFRB, platelet-derived growth factor receptor beta; SHH, Sonic Hedgehog; SMARCB1, SWItch/Sucrose Non-Fermentable–related, matrix-associated, actin-dependent regulator of chromatin, subfamily b, member 1; VEGFA, vascular endothelial growth factor A.